Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?
AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.
Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aveanna Healthcare Holdings Inc. (AVAH) Q2 2024 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q2 2024 Earnings Call August 8, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Scott Fidel - Stephens Inc A.J. Rice - UBS Pito Chickering - Deutsche Bank Operator Good morning and welcome to Aveanna Healthcare Holdings Second Quarter 2024 Earnings Conference Call.
Aveanna (AVAH) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.02 per share a year ago.
Curious about Aveanna (AVAH) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
As of July 16, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Best Momentum Stocks to Buy for July 12th
IKNA, AVAH, and VEL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 12, 2024.
Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
Here is how Aveanna Healthcare (AVAH) and Alcon (ALC) have performed compared to their sector so far this year.
